Background: Familial dysbetalipoproteinemia (FD), also known as type III hyperlipoproteinemia, is a genetic dyslipidemia characterized by elevated very low density lipoprotein (VLDL) and chylomicron remnant particles that confers increased risk of cardiovascular disease (CVD). The objective of this study was to evaluate the prevalence of vascular risk factors, CVD, lipid values, treatment and lipid targets in patients with FD across Europe.Methods: This cross-sectional study was performed in 305 patients with FD from seven academic hospitals in four European countries. Information was collected from clinical records.Results: Patients mean (+/- standard deviation) age was 60.9 +/- 14.4 years, 201 (66%) were male, 69 (23%) had diabetes mellit...
Background and aims: Familial combined hyperlipidemia (FCHL) is a complex dyslipidemia associated wi...
Background: The European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboratio...
Background and aims: Familial hypercholesterolemia (FH) is the most relevant genetic cause of early ...
Background: Familial dysbetalipoproteinemia (FD), also known as type III hyperlipoproteinemia, is a ...
Background: Familial dysbetalipoproteinemia (FD), also known as type III hyperlipoproteinemia, is a ...
BACKGROUND: Familial dysbetalipoproteinemia (FD), also known as type III hyperlipoproteinemia, is a ...
Background Cardiovascular disease (CVD) is a large worldwide medical burden, with yearly increasing ...
Background and aims: Familial hypercholesterolemia (FH) is a life-threatening disease, characterized...
Author: Gintarė Valterytė Title: Identification of Patients with Familial Hypercholesterolemia (FH) ...
Background and aims: Familial hypercholesterolemia (FH) is an inherited disorder of lipoprotein meta...
IntroductionThe recent EAS consensus paper on familial hypercholesterolæmia (FH) indicates a higher ...
Background and aims: Familial hypercholesterolaemia (FH) is a powerful risk factor for cardiovascula...
Cardiovascular disease (CVD) remains the most common cause of death globally. Dyslipidaemia is one o...
Background: Familial hypercholesterolemia (FH) is a common autosomal dominant disorder caused by mu...
BACKGROUND: Heterozygous familial hypercholesterolemia (hFH) and familial combined hyperlipidemia (F...
Background and aims: Familial combined hyperlipidemia (FCHL) is a complex dyslipidemia associated wi...
Background: The European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboratio...
Background and aims: Familial hypercholesterolemia (FH) is the most relevant genetic cause of early ...
Background: Familial dysbetalipoproteinemia (FD), also known as type III hyperlipoproteinemia, is a ...
Background: Familial dysbetalipoproteinemia (FD), also known as type III hyperlipoproteinemia, is a ...
BACKGROUND: Familial dysbetalipoproteinemia (FD), also known as type III hyperlipoproteinemia, is a ...
Background Cardiovascular disease (CVD) is a large worldwide medical burden, with yearly increasing ...
Background and aims: Familial hypercholesterolemia (FH) is a life-threatening disease, characterized...
Author: Gintarė Valterytė Title: Identification of Patients with Familial Hypercholesterolemia (FH) ...
Background and aims: Familial hypercholesterolemia (FH) is an inherited disorder of lipoprotein meta...
IntroductionThe recent EAS consensus paper on familial hypercholesterolæmia (FH) indicates a higher ...
Background and aims: Familial hypercholesterolaemia (FH) is a powerful risk factor for cardiovascula...
Cardiovascular disease (CVD) remains the most common cause of death globally. Dyslipidaemia is one o...
Background: Familial hypercholesterolemia (FH) is a common autosomal dominant disorder caused by mu...
BACKGROUND: Heterozygous familial hypercholesterolemia (hFH) and familial combined hyperlipidemia (F...
Background and aims: Familial combined hyperlipidemia (FCHL) is a complex dyslipidemia associated wi...
Background: The European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboratio...
Background and aims: Familial hypercholesterolemia (FH) is the most relevant genetic cause of early ...